Plantar verrucae in patients with human immunodeficiency virus: Clinical presentation and treatment response

Journal of the American Podiatric Medical Association

Volumn 91, Issue 2, 2001, Pages 79-84

  Whitaker, Jeffrey M ^b   Gaggero, Geoffrey L ^b   Loveland, Lacey ^b   Segura, Lolita ^a   Barbosa, Peter ^a,b  

^a California College of Pediatric Medicine San Francisco Campus   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; LACTIC ACID DERIVATIVE; PYROXYLIN; SALACTOL; SALICYLIC ACID DERIVATIVE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CURETTAGE; DRUG COMBINATION; FOOT DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SERODIAGNOSIS; TREATMENT OUTCOME; UNITED STATES; VERRUCA VULGARIS;

COLLODION; CURETTAGE; DERMATOLOGIC AGENTS; DRUG COMBINATIONS; FOOT DISEASES; HIV SERONEGATIVITY; HIV SEROPOSITIVITY; HUMANS; LACTATES; PILOT PROJECTS; SALICYLIC ACIDS; SAN FRANCISCO; TREATMENT OUTCOME; WARTS;

EID: 0035259036     PISSN: 87507315     EISSN: None     Source Type: Journal    
DOI: 10.7547/87507315-91-2-79     Document Type: Article

References (15)

1. MEBERG R, KENYON E, BIERMAN R, ET AL: Characterization of plantar verrucae among individuals with human immunodeficiency virus. JAPMA 88: 442, 1998.
2. KIRBY EJ, SHEREFF MJ, LEWIS MM: Soft-tissue tumors and tumor-like lesions of the foot: an analysis of eighty-three cases. J Bone Joint Surg Am 71: 621, 1989.
3. FIELDS B, KNIPE D: Fields Virology, 2nd Ed, Raven Press, New York, 1990.
4. BROOKS G, BUTEL J, ORNSTON L: Jawetz, Melnick, and Adelberg's Medical Microbiology, 19th Ed, Appleton & Lange, Norfolk, CT, 1991.
5. BUNNEY M, BENTON C, CUBIE H: Viral Warts: Biology and Treatment, 2nd Ed, Oxford Medical Publications, Oxford, 1992.
6. VIAC J, CHOMEL J, CHARDONNET Y, ET AL: Incidence of antibodies to human papillomavirus type 1 in patients with cutaneous and mucosal papillomas. J Med Virol 32: 18, 1990.
7. JENKIN W: "Management of Viral Infections of the Skin and Nail," in Surgery Lecture Manual, p 14, California College of Podiatric Medicine, San Francisco, 1994.
8. MEMAR O, CIRELLI R, LEE P, ET AL: Cutaneous manifestations of HIV-1 infection. JAPMA 85: 362, 1995.
9. BARBOSA P: Plantar verrucae and HIV infection. Clin Podiatr Med Surg 15: 317, 1998.
10. KANG S, FITZPATRICK T: Debilitating verruca vulgaris in a patient infected with the human immunodeficiency virus. Arch Dermatol 130: 294, 1994.
11. BURNS S: Podiatric manifestations of AIDS. JAPMA 80: 15, 1990.
12. ADLER J: Pedal infectious disease associated with acquired immunodeficiency syndrome. Clin Podiatr Med Surg 9: 837, 1992.
13. DOVER J, JOHNSON R: Cutaneous manifestations of human immunodeficiency virus infection. Arch Dermatol 27: 1383, 1991.
14. SOLTANI SK, KENYON E, BARBOSA P: Chronic and aggressive plantar verrucae in a patient with HIV. JAPMA 86: 555, 1996.
15. KENYON E, LOVELAND L, KILPATRICK R, ET AL: Epidemiology of plantar verrucae in HIV-infected individuals. J Acquir Immune Defic Syndr Hum Retrovirol 17: 94, 1998.